| Pharmaceutical active ingredients: |
| Norfloxacin |
| Available forms, composition and doses of Renoxacin: |
| N / A |
| Renoxacin medical category: |
| Human:Ear anti-infectives and antisepticsEye anti-infectives and antisepticsQuinolones |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01MA06 - NorfloxacinS01AX12 - Norfloxacin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| So.Se. Pharm |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Renovist II | Diatrizoate Meglumine; Diatrizoate Sodium | Bristol-Myers Squibb; Bracco |
| Renovue | Iodamide Meglumine | Bristol-Myers Squibb; Bracco |
| Renovue-DIP | Iodamide Meglumine | Unidentified Pharmaceutical Company |
| Renox | Lornoxicam | Shince Pharmaceuticals |
| Renox-A | Acetaminophen; Lornoxicam | Shince Pharmaceuticals |
| Renpress | Spirapril Hydrochloride | Valeant Pharmaceuticals; Zentiva |
| Rensed | Levomepromazine Maleate | Laboratorio Medico Quimico Biologico |
| Renselin | Undecylenic Acid | Unidentified Pharmaceutical Company |
| Rentamine Pediatric | Carbetapentane Tannate; Chlorpheniramine Tannate; Ephedrine Tannate; Phenylephrine Tannate | The Harvard Drug Group |
| Rentibloc | Sotalol Hydrochloride | Shire; Dr. Rentschler Arzneimittel |